Delivery Order SPE2DB22D3016-SPE2DB23FAZQ2
Award Date
4/27/23
Potential Completion Date
4/28/23
Potential Value
$3.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,485.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of XCOPRI 100 MG TABLET 30S, a pharmaceutical product, with a completion date of September 20, 2023. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This award is not designated with any set-aside requirements, indicating full and open competition. Amerisourcebergen Drug...
This federal contract award, valued at $1,197.14, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of a pharmaceutical product, XCOPRI 50 MG TABLET 30S, and does not have any set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,287.11 firm fixed-price delivery order is for the supply of XCOPRI 100 MG TABLET 30S, a pharmaceutical product. The award has an ultimate completion date of May 6, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $3,186.08, is a delivery order for the pharmaceutical product XCOPRI 50 MG TABLET 30S. The award has an ultimate completion date of May 7, 2024 and is a firm fixed-price contract. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of XCOPRI 100 MG TABLET 30S. The contract, with a ceiling value of $2,165.36, is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $3,170.64 firm fixed-price delivery order is for the pharmaceutical product XCOPRI 200 MG TABLET 30S, and has an ultimate completion date of May 3, 2024. The contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to...
This federal contract award, valued at $2,693.21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of XCOPRI 200 mg tablets, a prescription medication, to support military and veterans' healthcare programs. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to...
This federal contract award, SPE2DX15D3013|SPE2DX24FH0H5, was issued by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA), to Amerisourcebergen Drug Corp, a wholly-owned subsidiary of Cencora, Inc. The contract is for the delivery of XCOPRI 200 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $1,692.07 and a completion date of December 8, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,918.68 firm fixed-price delivery order is for the supply of XCOPRI 200 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of May 23, 2023 and was awarded on May 22, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,630.25, is a Delivery Order for the supply of XCOPRI 100 MG TABLET 30S, a medical product. The contract has a firm fixed price and an ultimate completion date of February 18, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...